ARCHIVES

NSABP Researcher Committed Misconduct, NIH Investigation Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 11 | March 18, 1994

Download PDF Visit The Full Archive

Related Articles

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

Wisconsin Funds State Cancer Control Program

July 15, 1988

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989